1 Lazo M, Hernaez R, Eberhardt MS, et al. Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol, 2013,178: 38-45.
2 Huang Y, He S, Li JZ, et al. A feed-forward loop amplifies nutritional regulation of PNPLA3. Proc Natl Acad Sci U S A, 2010,107: 7892-7897.
3 Dongiovanni P, Donati B, Fares R, et al. PNPLA3 I148M polymorphism and progressive liver disease. World J Gastroenterol, 2013,19: 6969-6978.
4 Hyysalo J, Gopalacharyulu P, Bian H, et al. Circulating Triacylglycerol Signatures in Nonalcoholic Fatty Liver Disease Associated With the I148M Variant in PNPLA3 and With Obesity. Diabetes, 2014,63: 312-322.
5 Naik A, Kosir R, Rozman D. Genomic aspects of NAFLD pathogenesis. Genomics, 2013,102: 84-95.
6 Li YY. Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease. World J Gastroenterol, 2012,18: 6546-6551.
7 Semple RK, Sleigh A, Murgatroyd PR, et al. Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. J Clin Invest, 2009,119: 315-322.
8 Birkenfeld AL, Shulman GI. Nonalcoholic Fatty Liver Disease, Hepatic Insulin Resistance, and Type 2 Diabetes. Hepatology, 2014,59: 713-723.
9 Asrih M, Jornayvaz FR. Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance. J Endocrinol, 2013,218: R25-R36.
10 Gruben N, Shiri-Sverdlov R, Koonen DPY, et al. Nonalcoholic fatty liver disease: A main driver of insulin resistance or a dangerous liaison? Biochim Biophys Acta, 2014,1842: 2329-2343.
11 Chavez-Tapia NC, Rosso N, Tiribelli C. Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease. Bmc Gastroenterol, 2012,12.
12 Cohen JC, Horton JD, Hobbs HH. Human fatty liver disease: old questions and new insights. Science, 2011,332: 1519-1523.
13 Kawano Y, Cohen DE. Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease. J Gastroenterol, 2013,48: 434-441.
14 Sahini N, Borlak J. Recent insights into the molecular pathophysiology of lipid droplet formation in hepatocytes. Prog Lipid Res, 2014,54: 86-112.
15 Farrell GC, van Rooyen D, et al. NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications. Gut Liver, 2012,6: 149-171.
16 Leamy AK, Egnatchik RA, Young JD. Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease. Prog Lipid Res, 2013,52: 165-174.
17 Rolo AP, Teodoro JS, Palmeira CM. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic Biol Med, 2012,52: 59-69.
18 Demeilliers C, Maisonneuve C, Grodet A, et al. Impaired adaptive resynthesis and prolonged depletion of hepatic mitochondrial DNA after repeated alcohol binges in mice. Gastroenterology, 2002,123: 1278-1290.
19 Paradies G, Paradies V, et al. Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease. World J Gastroenterol, 2014,20: 14205-14218.
20 Leung TM, Nieto N. CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease. J Hepatol, 2013,58: 395-398.
21 Stanton MC, Chen SC, Jackson JV, et al. Inflammatory Signals shift from adipose to liver during high fat feeding and influence the development of steatohepatitis in mice. J Inflamm (Lond), 2011,8: 8.
22 Mencin A, Kluwe J, Schwabe RF. Toll-like receptors as targets in chronic liver diseases. Gut, 2009,58: 704-720.
23 Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature Rev Immunol, 2006,6: 772-783.
24 Hotamisligil GS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell, 2010,140: 900-917.
25 Zhang XQ, Xu CF, Yu CH, et al. Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol, 2014,20: 1768-1776.
26 Lozupone CA, Stombaugh JI, et al. Diversity, stability and resilience of the human gut microbiota. Nature, 2012,489: 220-230.
27 Henao-Mejia J, Elinav E, Jin CC, et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature, 2012,482: 179-U167. |
